Yoshifumi Shirakami

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: ⁶⁴Cu- and ²²⁵Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models

Tadashi Watabe, Yuwei Liu, Kazuko Kaneda‐Nakashima et al. · Journal of Nuclear Medicine · 2019 · 303 citations · Full text

Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model

Yuwei Liu, Tadashi Watabe, Kazuko Kaneda‐Nakashima et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 168 citations · Full text

Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells

Shuntaro Oka, Hiroyuki Okudaira, Yasunori Yoshida et al. · Nuclear Medicine and Biology · 2011 · 119 citations

Biochemistry, Prostate Cancer Cells, Anti-cancer Agent +3

Metabolism of iodine-123-BMIPP in perfused rat hearts.

Yoshihiro Yamamichi, Hideo Kusuoka, Kenichi Morishita et al. · PubMed · 1995 · 98 citations

Enhancement of²¹¹At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer

Tadashi Watabe, Kazuko Kaneda‐Nakashima, Yuwei Liu et al. · Journal of Nuclear Medicine · 2019 · 90 citations · Full text